Role of Alpha-lipoic Acid in Diabetes Melitus Type 1
NCT05679037 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2023-01-10
Summary
This study aims at investigating the possible effect of alpha-lipoic acid on endothelial dysfunction and atherosclerosis in children with type 1 diabetes mellitus.
Conditions
- Diabetes MellitusType 1
Interventions
- OTHER
-
Placebo
Inactive capsules
- DRUG
-
Alpha Lipoic Acid 600 MG Oral Capsule
Universal antioxidant
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2024-10-31
- Completion
- 2024-11-30
More Related Trials
-
Effect of Fiber Supplementation in Children With Type 1 Diabetes
NCT01399892 ·Status: COMPLETED ·Phase: NA
-
Oxidative Stress, Carbohydrate Metabolism Disorders and G6PD Deficiency
NCT05571748 ·Status: UNKNOWN ·Phase: NA
-
Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
NCT00490867 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Low Carbohydrate Diet in Reducing Polypharmacy for Patients With Type 2 Diabetes Mellitus
NCT03176056 ·Status: COMPLETED ·Phase: NA
-
Reactive Oxygen Species in the Pathogenesis of Diabetic Complications
NCT00703989 ·Status: COMPLETED ·Phase: NA
-
ALA on Glycemic Control in T2DM Participants
NCT02701894 ·Status: UNKNOWN
-
Effects of 5-Aminolevulinic Acid on Glucose Metabolism
NCT01610778 ·Status: COMPLETED ·Phase: NA
-
Effect of Coenzyme Q10 on Diabetic Children
NCT06361680 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Impact of Alpha-Lipoic Acid Ingestion on Glucose Tolerance in Subjects With Pre-Diabetes
NCT03612037 ·Status: COMPLETED ·Phase: NA
-
GABA Treatment in Subjects With Type 1 Diabetes
NCT03721991 ·Status: UNKNOWN ·Phase: NA
-
Effects of Liposomal Encapsulation on Vitamin C Absorption and Metabolism
NCT06372171 ·Status: RECRUITING ·Phase: NA
-
Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes
NCT00592072 ·Status: COMPLETED ·Phase: NA
-
The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
NCT00398892 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients
NCT01241695 ·Status: COMPLETED ·Phase: NA
-
Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes
NCT04635670 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Stevia in Type 2 Diabetic Patients
NCT02834715 ·Status: COMPLETED ·Phase: NA
-
Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
NCT05737342 ·Status: RECRUITING ·Phase: NA
-
Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus
NCT00985361 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of Efficacy of Intra-muscular Vitamin D3 in Tropical Calcific Pancreatitis
NCT00956839 ·Status: COMPLETED ·Phase: PHASE4
-
Short-term Effects of Carbohydrate-restricted Diet on Glycemic and Metabolic Control Among Children and Adolescent With Type 1 Diabetes Mellitus
NCT06699485 ·Status: COMPLETED ·Phase: NA
-
Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes
NCT00417950 ·Status: UNKNOWN ·Phase: NA
-
5-MTHF Supplementation for Treatment of Type 1 Diabetes Patients
NCT06930144 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Glycemic Response of Co-ingesting Carbohydrate and Amino Acids
NCT02455765 ·Status: COMPLETED ·Phase: NA
-
Prebiotic Fiber Supplement in T1DM Children
NCT02442544 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients
NCT02274272 ·Status: COMPLETED ·Phase: PHASE2